The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Abstract
Alzheimer disease (AD) is a neurodegenerative disorder and the most common form of dementia. Histopathologically is characterized by the presence extracellular neuritic plaques and with a large number of neurons lost. In this paper, we design a new nanomaterial, graphene quantum dots (GQDs) conjugated neuroprotective peptide glycine-proline-glutamate (GQDG) and administer it to APP/PS1 transgenic mice. The in vitro assays including ThT and CD proved that GQDs and GQDG could inhibit the aggregation of Aβ1-42 fibrils. Morris water maze was performed to exanimate learning and memory capacity of APP/PS1 transgenic mice. The surface area of Aβ plaque deposits reduced in the GQDG group compared to the Tg Ctrl groups. Furthermore, newly generated neuronal precursor cell and neuron were test by immunohistochemical. Besides, neurons were impregnated by DiI using gene gun to show dendritic spine. Results indicated enhancement of learning and memory capacity and increased amounts of dendritic spine were observed. Inflammation factors and amyloid-β (Aβ) were tested with suspension array and ELISA, respectively. Several pro-inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-33, IL-17α, MIP-1β and TNF-α) had decreased in GQDG group compared with Control group. Reversely, anti-inflammatory cytokines (IL-4, IL-10) had increased in GQDG group compared with Control group. Thus, we demonstrate that the GQDG is a promising drug in treatment of neurodegenerative diseases such as AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Xiao et al. (2016) used graphene quantum dots (GQDs) coated with glycine-proline-glutamate in APP/PS1 transgenic mice. The aggregation of amyloid plaque along with the levels of pro-inflammatory cytokines was reduced whereas the levels of anti-inflammatory cytokines increased, thus demonstrating strong potential as a therapy in AD [112].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [112]
Citations
Cites
Preparation of Graphitic Oxide
Hummers, W. S., & Offeman, R. E. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01539a017 · Cited by 30,194
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Graphene and Graphene Oxide: Synthesis, Properties, and Applications
Zhu, Y., Murali, S., Cai, W., Li, X., Suk, J. W., Potts, J. R., & Ruoff, R. S. (2010) · Advanced Materials · doi:10.1002/adma.201001068 · Cited by 10,653
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Nano-graphene oxide for cellular imaging and drug delivery
Sun, X., Liu, Z., Welsher, K., Robinson, J. T., Goodwin, A. P., Zaric, S., & Dai, H. (2008) · Nano Research · doi:10.1007/s12274-008-8021-8 · Cited by 3,318
LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,284
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 2×
“[4] Karran E, Mercken M, De Strooper B.”
BackgroundAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Strongly green-photoluminescent graphene quantum dots for bioimaging applications
Zhu, S., Zhang, J., Qiao, C., Tang, S., Li, Y., Yuan, W., Li, B., Tian, L., Liu, F., Hu, R., et al. (2011) · Chemical Communications · doi:10.1039/c1cc11122a · Cited by 1,601
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Focusing on luminescent graphene quantum dots: current status and future perspectives
Li, L., Wu, G., Yang, G., Peng, J., Zhao, J., & Zhu, J. (2013) · Nanoscale · doi:10.1039/c3nr33849e · Cited by 1,488
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006) · Nature Neuroscience · doi:10.1038/nn1629 · Cited by 1,209
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Korsching, S. I., Auburger, G. W. J., Heumann, R., Scott, J., & Thoenen, H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03791.x · Cited by 938
Kitts, D., & Weiler, K. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454883 · Cited by 910
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/756357 · Cited by 864
Cytokines and the nervous system I: expression and recognition
Hopkins, S. J., & Rothwell, N. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80029-2 · Cited by 793
Tyler, W. J., Alonso, M., Bramham, C. R., & Pozzo‐Miller, L. D. (2002) · Learning & Memory · doi:10.1101/lm.51202 · Cited by 699
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease
Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546
In Vivo Biodistribution and Toxicology of Carboxylated Graphene Quantum Dots
Nurunnabi, M., Khatun, Z., Huh, K. M., Park, S. Y., Lee, D. Y., Cho, K.-J., & Lee, Y.-K. (2013) · ACS Nano · doi:10.1021/nn402043c · Cited by 546
The in vitro and in vivo toxicity of graphene quantum dots
Chong, Y., Ma, Y., Shen, H., Tu, X., Zhou, X., Xu, J., Dai, J., Fan, S., & Zhang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.021 · Cited by 531
Self-citationInterleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials
Gadient, R. A., & Otten, U. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00021-x · Cited by 481
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia
Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2432 · Cited by 401
Inflammasomes in neuroinflammation and changes in brain function: a focused review
Singhal, G., Jaehne, E. J., Corrigan, F., Toben, C. G., & Baune, B. T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00315 · Cited by 372
Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328
Inflammatory factors are elevated in brain microvessels in Alzheimer's disease
Grammas, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00276-7 · Cited by 298
McAlpine, F. E., Lee, J., Harms, A. S., Ruhn, K. A., Blurton-Jones, M. M., Hong, J. J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 274
Dendrite and dendritic spine alterations in alzheimer models
Moolman, D. L., Vitolo, O. V., Vonsattel, J.-P. G., & Shelanski, M. L. (2004) · Journal of Neurocytology · doi:10.1023/b:neur.0000044197.83514.64 · Cited by 245
Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 236
Graphene oxide strongly inhibits amyloid beta fibrillation
Mahmoudi, M., Akhavan, O., Ghavami, M., Rezaee, F., & Ghiasi, S. M. A. (2012) · Nanoscale · doi:10.1039/c2nr31657a · Cited by 232
Minkeviciene, R., Ihalainen, J. A., Malm, T., Matilainen, O., Keksa-Goldsteine, V., Goldsteins, G., Iivonen, H., Leguit, N., Glennon, J. C., Koıstınaho, J., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05147.x · Cited by 210
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.015 · Cited by 174
Graphene quantum dots for the inhibition of β amyloid aggregation
Liu, Y., Xu, L., Dai, W., Dong, H., Wen, Y., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr06282a · Cited by 164
Ringheim, G., Burgher, K. L., & Heroux, J. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00134-4 · Cited by 159
Nurunnabi, M., Khatun, Z., Nafiujjaman, M., Lee, D.-G., & Lee, Y.-K. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am4023863 · Cited by 158
Demeritte, T., Nellore, B. P. V., Kanchanapally, R., Sinha, S. S., Pramanik, A., Chavva, S. R., & Ray, P. C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03619 · Cited by 154
Fluorescent graphene quantum dots as traceable, pH-sensitive drug delivery systems
Liu, H., Qiu, J., Zhang, R., Li, J., Sang, Y., Tang, W., & Rivera-Gil, P. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91864 · Cited by 139
Faure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112
Large Graphene Quantum Dots Alleviate Immune-Mediated Liver Damage
Volarević, V., Paunović, V., Marković, Z. M., Marković, B. S., Misirkic-Marjanovic, M., Marković, B. M. T., Bojić, S., Vucicevic, L. M., Jovanović, S., Arsenijević, N., et al. (2014) · ACS Nano · doi:10.1021/nn502466z · Cited by 101
Modi, K. K., Roy, A., Brahmachari, S., Rangasamy, S. B., & Pahan, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130398 · Cited by 100
Guan, J., Thomas, G. B., Lin, H., Mathai, S., Batchelor, D. C., George, S., & Gluckman, P. D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.002 · Cited by 85
Nanotechnology for neurodegenerative disorders
Re, F., Gregori, M., & Masserini, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.007 · Cited by 84
Wang, X., Lei, R., Huang, H.-D., Wang, N., Yuan, L., Xiao, R., Bai, L.-D., Li, X., Li, L., & Yang, X. (2014) · Nanoscale · doi:10.1039/c4nr04136d · Cited by 79
Zimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 78
Association between the TNFα‐308 A/G polymorphism and the onset‐age of Alzheimer disease
Álvarez, V., Mata, I. F., González, P., Lahoz, C., Martínez, C., Peña, J., Guisasola, L. M., & Coto, E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10515 · Cited by 75
Zhu, M., Allard, J. S., Zhang, Y., Perez, E., Spangler, E. L., Becker, K. G., & Rapp, P. R. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000060 · Cited by 69
Szczepanik, A. M., & Ringheim, G. E. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5205 · Cited by 61
Laursen, B., Mørk, A., Plath, N., Kristiansen, U., & Bastlund, J. F. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.012 · Cited by 58
DiOLISTIC Labeling of Neurons from Rodent and Non-human Primate Brain Slices
Seabold, G. K., Daunais, J. B., Rau, A. R., Grant, K. A., & Alvarez, V. A. (2010) · Journal of Visualized Experiments · doi:10.3791/2081 · Cited by 57
Hydroxypropyl-β-cyclodextrin–graphene oxide conjugates: Carriers for anti-cancer drugs
Tan, J., Meng, N., Fan, Y., Su, Y., Zhang, M., Xiao, Y., & Zhou, N. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.098 · Cited by 55
Diolistic labeling of neuronal cultures and intact tissue using a hand-held gene gun
O’Brien, J., & Lummis, S. C. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.258 · Cited by 53
The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders
Guan, J., Harris, P. W. R., Brimble, M. A., Lei, Y., Lü, J., Yang, Y., & Gunn, A. J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1010514 · Cited by 52
Zaheer, S. A., Thangavel, R., Wu, Y., Khan, M. M., Kempuraj, D., & Zaheer, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0913-z · Cited by 50
Nath, A., Chattopadhya, S., Chattopadhyay, U., & Sharma, N. K. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0149-3 · Cited by 43
Activated microglia and cerebral amyloid deposits in alzheimer's disease
Rozemüller, A. J. M., van der Valk, P., & Eikelenboom, P. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80050-u · Cited by 41
Solution‐Processable Graphene Quantum Dots
Zhou, X., Guo, S., & Zhang, J. (2013) · ChemPhysChem · doi:10.1002/cphc.201300111 · Cited by 32
Burgos‐Ramos, E., Martos‐Moreno, G. Á., López, M. G., Herranz, R., Aguado‐Llera, D., Egea, J., Frechilla, D., Cenarruzabeitia, E., Leon, R. M., Arilla, E., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05980.x · Cited by 31
Gly-Pro-Glu protects β-amyloid-induced somatostatin depletion in the rat cortex
Aguado‐Llera, D., Martín‐Martinez, M., García-López, M. T., Arilla, E., & Barrios, V. (2004) · Neuroreport · doi:10.1097/00001756-200408260-00029 · Cited by 24
Angelucci, F., Gelfo, F., Fiore, M., Croce, N., Mathé, A. A., Bernardini, S., & Caltagirone, C. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0099 · Cited by 23
Inflammation in Alzheimer's disease: a view from the periphery
Raine, C. S. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00138-x · Cited by 20
β-Amyloid Protein in Alzheimer's Disease
Nalbantoglu, J. N. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032595 · Cited by 12
Measurement of cytokine levels in cerebrospinal fluid over time in neonatal E nterococcal meningitis
Ikeda, N., Suganuma, H., Ohkawa, N., Nagata, S., Shoji, H., & Shimizu, T. (2014) · Pediatrics International · doi:10.1111/ped.12398 · Cited by 3
Cited by
Sorted by citations
Graphene quantum dots from chemistry to applications
Tian, P., Tang, L., Teng, K. S., & Lau, S. P. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.09.007 · Cited by 899
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
Quantum dots in imaging, drug delivery and sensor applications
Matea, C., Mocan, T., Tabaran, F., Pop, T., Mosteanu, O., Puia, C., Iancu, C., & Mocan, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138624 · Cited by 666
“The GQDGs had an inhibitory effect on the aggregation of amyloid-β fibrils, the number of newly generated neuronal precursor cells and neurons increased.(34)”
Cui, G., Wu, J., Mou, F., Xie, W., Wang, F., Wang, Q., Fang, J., Xu, Y., Dong, Y., Liu, J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700600r · Cited by 387
“The data presented in this study found a marked increase in the level of TNF-a and IL-1b and a decrease in the level of IL-4 and -10 in ADmice, which is consistent with a previous report (31).”
ResultSelf-citationCui, G.-H., Guo, H.-D., Li, H., Zhai, Y., Gong, Z., Wu, J., Liu, J.-S., Dong, Y., Hou, S., & Liu, J. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0150-2 · Cited by 359
Self-citation
Metadata
- Authors
- Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., Guo, R., & Liu, J.
- Affiliations
- Sun Yat-sen University (CN)
- Guangdong Provincial Hospital of Chinese Medicine (CN)
- Shenzhen University (CN)
- Jinan University (CN)
- Corresponding author
- Guo, Rui
- Liu, Jun
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 106
- Pages
- 98-110
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2514135347
- Cited by
- 169
- References
- 68
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 25 · 2023: 37 · 2022: 25 · 2021: 22 · 2020: 23 · 2019: 8 · 2018: 11 · 2017: 5
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shenzhen Fundamental Research and Discipline Layout project
- National Natural Science Foundation of China (81372919)
- Natural Science Foundation of Guangdong Province (51303064, 2014A030313016)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Materials Science › Materials Chemistry › Carbon and Quantum Dots Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- graphene quantum dots, neuroprotective peptides, Alzheimer's disease, amyloid beta aggregation inhibition, APP/PS1 mice, learning and memory, dendritic spines, neuroinflammation, inflammatory cytokines, anti-inflammatory cytokines, amyloid plaques, nanomaterial drug delivery
- MeSH terms
- Alzheimer Disease, Animals, Graphite, Learning, Male, Memory, Mice, Transgenic, Peptides, Treatment Outcome, Neuroprotective Agents, Quantum Dots, Mice, Nanoconjugates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
